Kissei Pharmaceutical Co., Ltd.
Notice Regarding the Results of Treasury Stock Acquisition by Off-Market Tender Offer (ToSTNeT-3)
Announces concrete results of share repurchase. Total number of shares acquired recorded: 1,032,500 shares; total acquisition price: 3,877,037,500 yen. Acquisition date: 2026-11-05, executed via an off-market tender offer using ToSTNeT-3. Cumulative acquisitions to date: 1,232,500 shares, total 4,676,349,000 yen.
Key Figures
- Total number of treasury shares acquired (this time): 1,032,500 shares (total amount 3,877,037,500 yen)
- Cumulative total number of shares acquired: 1,232,500 shares (cumulative total amount 4,676,349,000 yen)
- Acquisition date: 2026-11-05
AI要約
Overview of Capital Policy
Kissei Pharmaceutical Co., Ltd. implements treasury stock acquisitions to execute a flexible capital policy in response to changes in the business environment, to improve capital efficiency, and to enhance shareholder returns. The current acquisition was carried out through an off-market tender offer using ToSTNeT-3, resulting in the acquisition of 1,032,500 shares. The acquisition date was November 5, 2026, and the total acquisition amount was 3,877,037,500 yen. The cumulative number of shares acquired to date is 1,232,500 shares, and the cumulative acquisition amount is 4,676,349,000 yen.
Impact on Shareholders and Future Policy
Future limits on treasury stock acquisition and any additional acquisition policies are expected to be determined based on disclosed resolutions of the Board of Directors and other announcements. This measure is positioned as part of efforts to enhance shareholder returns and capital efficiency, and is considered important also from the perspective of anti-dilution measures.
Kissei Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
